CM Life Sciences III Inc.
Status: Closed Deal
U=S+W/5
W=S@11.5
| IPO Proceeds, $M | $552.00M |
|---|---|
| IPO Date | Apr 7, 2021 |
| CEO | Eli D. Casdin |
| Left Lead | Jefferies |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | EQRx |
| Deal Announced | Aug 6, 2021 |
| Deal Size, $M | $3,538.00M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Dec 16, 2021 |
| Amendment Vote | TBD |
| Closing Date | Dec 17, 2021 |
Formerly CMLT
EQRX
EQRXW
| Price | 2.24 |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.